User Experience Testing of <i>My ePRO App</i> in a Diabetes Mellitus Type 2 Focus Group

Christian Mueller; Isabel Schauerte; Stephan Martin

doi:doi:10.11648/j.ijcems.20220801.11

| Peer-Reviewed

User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group

Christian Mueller, Isabel Schauerte, Stephan Martin

Published in International Journal of Clinical and Experimental Medical Sciences (Volume 8, Issue 1)

Received: 5 November 2021 Accepted: 24 November 2021 Published: 20 January 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Type 2 Diabetes Mellitus affects patients’ quality of life. The my ePRO app was constructed to collect patient-reported outcomes in an investigator free study - DePRO study. We aimed to describe the qualitative and quantitative feedback received during user experience testing in a diabetes mellitus type 2 focus group. Methods: Metformin containing drug taking patients aged 18 years or older completed a 37-item qualitative questionnaire as the quantitative 6 scales and 26 items containing User Experience Questionnaire (UEQ) in a single focus group interview. The qualitative interview addressed feedback to 1) the download of the app, 2) scanning the 2D matrix code, 3) informed consent form, 4) demographic questionnaire and the 3 PRO instruments EQ-5D-5L, SDSCA and DTSQ. Results: Nine T2DM patients, 3 female and 6 male, aged 55-88 years were interviewed for 45 to 65 minutes. Patients expressed their need of lay language within the app, criticized the length of the informed consent form, the amount of health information, missed pictures of the drugs they scanned and judged the questions to income and education as too indiscreet. As positive feedback patient reported that everything was fine, the questions were self-explaining and could be read without glasses. The UEC scales (mean; variances) Perspicuity (0.722; 1.73), Efficiency (0.5; 0.89) and Novelty (0.25; 1.13) were rated neutral, Attractiveness (0.854: 0.63), Dependability (1.031; 0.1) and Stimulation (1.094; 0.39) represent a positive evaluation. Discussion: User experience testing provided insight into usage, challenges and areas of improvement of my ePRO app in a type 2 Diabetes Mellitus focus group. User experiences were implemented in the final app. The quantitative feedback was compared to a benchmark data set, to which the my ePRO app means were below average in all scales. Understanding patient view, leads to a better design of health apps and study conduct.

Published in	International Journal of Clinical and Experimental Medical Sciences (Volume 8, Issue 1)
DOI	10.11648/j.ijcems.20220801.11
Page(s)	1-8
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

User Experience, Diabetes Mellitus, Type 2, Patient Reported Outcome Measures, App

References

[1]	WHO. Global Report on Diabetes. 2016 [cited; Available from: https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=FDB178D793B4B42DA05CB322A4F4E271?sequence=1.
[2]	Federation ID. Diabetes Atlas. 2019 [cited; Available from: https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf.
[3]	Boyle JP, Thompson TJ, Gregg EW et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population health metrics 2010; 8: 29.
[4]	Saleh F, Mumu SJ, Ara F et al. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC public health 2014; 14: 431.
[5]	Sun W, Aodeng S, Tanimoto Y et al. Quality of life (QOL) of the community-dwelling elderly and associated factors: a population-based study in urban areas of China. Archives of gerontology and geriatrics 2015; 60: 311-6.
[6]	Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes care 2000; 23: 943-50.
[7]	Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic medicine: a journal of the British Diabetic Association 1990; 7: 445-51.
[8]	Herdman M, Gudex C, Lloyd A et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 2011; 20: 1727-36.
[9]	Directive 2011/62/EU of the European Parliament and of the Council. 2011 [cited; Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2011_62/dir_2011_62_en.pdf.
[10]	Harder H, Holroyd P, Burkinshaw L et al. A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment. Journal of cancer survivorship: research and practice 2017; 11: 732-42.
[11]	Coons JC, Patel R, Coley KC, Empey PE. Design and testing of Medivate, a mobile app to achieve medication list portability via Fast Healthcare Interoperability Resources. Journal of the American Pharmacists Association: JAPhA 2019; 59: S78-S85 e2.
[12]	Minen MT, Jalloh A, Ortega E et al. User Design and Experience Preferences in a Novel Smartphone Application for Migraine Management: A Think Aloud Study of the RELAXaHEAD Application. Pain medicine 2019; 20: 369-77.
[13]	210 DE. Ergonomics of human-system interaction - Part 210: Human-centred design for interactive systems. 2011-01.
[14]	Anderson K, Burford O, Emmerton L. Mobile Health Apps to Facilitate Self-Care: A Qualitative Study of User Experiences. PloS one 2016; 11: e0156164.
[15]	Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse education today 2004; 24: 105-12.
[16]	Laugwitz B, Held T, Schrepp M. Construction and Evaluation of a User Experience Questionnaire 2008.
[17]	Schrepp M, Hinderks A, Thomaschewski J. Applying the User Experience Questionnaire (UEQ) in Different Evaluation Scenarios 2014.
[18]	Schrepp M, Hinderks A, Thomaschewski J. Construction of a Benchmark for the User Experience Questionnaire (UEQ). International Journal of Interactive Multimedia and Artificial Intelligence 2017; 4: 40-4.
[19]	Schrepp M. User Experience Questionnaire Handbook 2019 31.12.2019 [cited 10.11.2020]; Version 8: [Available from: https://www.ueq-online.org/Material/Handbook.pdf.
[20]	Tatara N, Arsand E, Skrovseth SO, Hartvigsen G. Long-term engagement with a mobile self-management system for people with type 2 diabetes. JMIR mHealth and uHealth 2013; 1: e1.
[21]	Asklund I, Samuelsson E, Hamberg K et al. User Experience of an App-Based Treatment for Stress Urinary Incontinence: Qualitative Interview Study. Journal of medical Internet research 2019; 21: e11296.

Cite This Article

Plain Text BibTeX RIS

APA Style

Christian Mueller, Isabel Schauerte, Stephan Martin. (2022). User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. International Journal of Clinical and Experimental Medical Sciences, 8(1), 1-8. https://doi.org/10.11648/j.ijcems.20220801.11

Copy | Download

ACS Style

Christian Mueller; Isabel Schauerte; Stephan Martin. User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. Int. J. Clin. Exp. Med. Sci. 2022, 8(1), 1-8. doi: 10.11648/j.ijcems.20220801.11

Copy | Download

AMA Style

Christian Mueller, Isabel Schauerte, Stephan Martin. User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. Int J Clin Exp Med Sci. 2022;8(1):1-8. doi: 10.11648/j.ijcems.20220801.11

Copy | Download

@article{10.11648/j.ijcems.20220801.11,
  author = {Christian Mueller and Isabel Schauerte and Stephan Martin},
  title = {User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {8},
  number = {1},
  pages = {1-8},
  doi = {10.11648/j.ijcems.20220801.11},
  url = {https://doi.org/10.11648/j.ijcems.20220801.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20220801.11},
  abstract = {Background: Type 2 Diabetes Mellitus affects patients’ quality of life. The my ePRO app was constructed to collect patient-reported outcomes in an investigator free study - DePRO study. We aimed to describe the qualitative and quantitative feedback received during user experience testing in a diabetes mellitus type 2 focus group. Methods: Metformin containing drug taking patients aged 18 years or older completed a 37-item qualitative questionnaire as the quantitative 6 scales and 26 items containing User Experience Questionnaire (UEQ) in a single focus group interview. The qualitative interview addressed feedback to 1) the download of the app, 2) scanning the 2D matrix code, 3) informed consent form, 4) demographic questionnaire and the 3 PRO instruments EQ-5D-5L, SDSCA and DTSQ. Results: Nine T2DM patients, 3 female and 6 male, aged 55-88 years were interviewed for 45 to 65 minutes. Patients expressed their need of lay language within the app, criticized the length of the informed consent form, the amount of health information, missed pictures of the drugs they scanned and judged the questions to income and education as too indiscreet. As positive feedback patient reported that everything was fine, the questions were self-explaining and could be read without glasses. The UEC scales (mean; variances) Perspicuity (0.722; 1.73), Efficiency (0.5; 0.89) and Novelty (0.25; 1.13) were rated neutral, Attractiveness (0.854: 0.63), Dependability (1.031; 0.1) and Stimulation (1.094; 0.39) represent a positive evaluation. Discussion: User experience testing provided insight into usage, challenges and areas of improvement of my ePRO app in a type 2 Diabetes Mellitus focus group. User experiences were implemented in the final app. The quantitative feedback was compared to a benchmark data set, to which the my ePRO app means were below average in all scales. Understanding patient view, leads to a better design of health apps and study conduct.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group
AU  - Christian Mueller
AU  - Isabel Schauerte
AU  - Stephan Martin
Y1  - 2022/01/20
PY  - 2022
N1  - https://doi.org/10.11648/j.ijcems.20220801.11
DO  - 10.11648/j.ijcems.20220801.11
T2  - International Journal of Clinical and Experimental Medical Sciences
JF  - International Journal of Clinical and Experimental Medical Sciences
JO  - International Journal of Clinical and Experimental Medical Sciences
SP  - 1
EP  - 8
PB  - Science Publishing Group
SN  - 2469-8032
UR  - https://doi.org/10.11648/j.ijcems.20220801.11
AB  - Background: Type 2 Diabetes Mellitus affects patients’ quality of life. The my ePRO app was constructed to collect patient-reported outcomes in an investigator free study - DePRO study. We aimed to describe the qualitative and quantitative feedback received during user experience testing in a diabetes mellitus type 2 focus group. Methods: Metformin containing drug taking patients aged 18 years or older completed a 37-item qualitative questionnaire as the quantitative 6 scales and 26 items containing User Experience Questionnaire (UEQ) in a single focus group interview. The qualitative interview addressed feedback to 1) the download of the app, 2) scanning the 2D matrix code, 3) informed consent form, 4) demographic questionnaire and the 3 PRO instruments EQ-5D-5L, SDSCA and DTSQ. Results: Nine T2DM patients, 3 female and 6 male, aged 55-88 years were interviewed for 45 to 65 minutes. Patients expressed their need of lay language within the app, criticized the length of the informed consent form, the amount of health information, missed pictures of the drugs they scanned and judged the questions to income and education as too indiscreet. As positive feedback patient reported that everything was fine, the questions were self-explaining and could be read without glasses. The UEC scales (mean; variances) Perspicuity (0.722; 1.73), Efficiency (0.5; 0.89) and Novelty (0.25; 1.13) were rated neutral, Attractiveness (0.854: 0.63), Dependability (1.031; 0.1) and Stimulation (1.094; 0.39) represent a positive evaluation. Discussion: User experience testing provided insight into usage, challenges and areas of improvement of my ePRO app in a type 2 Diabetes Mellitus focus group. User experiences were implemented in the final app. The quantitative feedback was compared to a benchmark data set, to which the my ePRO app means were below average in all scales. Understanding patient view, leads to a better design of health apps and study conduct.
VL  - 8
IS  - 1
ER  -

Copy | Download

Author Information

Christian Mueller

Bayer Vital GmbH, Leverkusen, Germany
Isabel Schauerte

Institut Dr. Schauerte, Munich, Germany
Stephan Martin

Westdeutsches Diabetes- und Gesundheitszentrum, Düsseldorf, Germany

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Christian Mueller, Isabel Schauerte, Stephan Martin. (2022). User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. International Journal of Clinical and Experimental Medical Sciences, 8(1), 1-8. https://doi.org/10.11648/j.ijcems.20220801.11

Copy | Download

ACS Style

Christian Mueller; Isabel Schauerte; Stephan Martin. User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. Int. J. Clin. Exp. Med. Sci. 2022, 8(1), 1-8. doi: 10.11648/j.ijcems.20220801.11

Copy | Download

AMA Style

Christian Mueller, Isabel Schauerte, Stephan Martin. User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group. Int J Clin Exp Med Sci. 2022;8(1):1-8. doi: 10.11648/j.ijcems.20220801.11

Copy | Download

@article{10.11648/j.ijcems.20220801.11,
  author = {Christian Mueller and Isabel Schauerte and Stephan Martin},
  title = {User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {8},
  number = {1},
  pages = {1-8},
  doi = {10.11648/j.ijcems.20220801.11},
  url = {https://doi.org/10.11648/j.ijcems.20220801.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20220801.11},
  abstract = {Background: Type 2 Diabetes Mellitus affects patients’ quality of life. The my ePRO app was constructed to collect patient-reported outcomes in an investigator free study - DePRO study. We aimed to describe the qualitative and quantitative feedback received during user experience testing in a diabetes mellitus type 2 focus group. Methods: Metformin containing drug taking patients aged 18 years or older completed a 37-item qualitative questionnaire as the quantitative 6 scales and 26 items containing User Experience Questionnaire (UEQ) in a single focus group interview. The qualitative interview addressed feedback to 1) the download of the app, 2) scanning the 2D matrix code, 3) informed consent form, 4) demographic questionnaire and the 3 PRO instruments EQ-5D-5L, SDSCA and DTSQ. Results: Nine T2DM patients, 3 female and 6 male, aged 55-88 years were interviewed for 45 to 65 minutes. Patients expressed their need of lay language within the app, criticized the length of the informed consent form, the amount of health information, missed pictures of the drugs they scanned and judged the questions to income and education as too indiscreet. As positive feedback patient reported that everything was fine, the questions were self-explaining and could be read without glasses. The UEC scales (mean; variances) Perspicuity (0.722; 1.73), Efficiency (0.5; 0.89) and Novelty (0.25; 1.13) were rated neutral, Attractiveness (0.854: 0.63), Dependability (1.031; 0.1) and Stimulation (1.094; 0.39) represent a positive evaluation. Discussion: User experience testing provided insight into usage, challenges and areas of improvement of my ePRO app in a type 2 Diabetes Mellitus focus group. User experiences were implemented in the final app. The quantitative feedback was compared to a benchmark data set, to which the my ePRO app means were below average in all scales. Understanding patient view, leads to a better design of health apps and study conduct.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - User Experience Testing of My ePRO App in a Diabetes Mellitus Type 2 Focus Group
AU  - Christian Mueller
AU  - Isabel Schauerte
AU  - Stephan Martin
Y1  - 2022/01/20
PY  - 2022
N1  - https://doi.org/10.11648/j.ijcems.20220801.11
DO  - 10.11648/j.ijcems.20220801.11
T2  - International Journal of Clinical and Experimental Medical Sciences
JF  - International Journal of Clinical and Experimental Medical Sciences
JO  - International Journal of Clinical and Experimental Medical Sciences
SP  - 1
EP  - 8
PB  - Science Publishing Group
SN  - 2469-8032
UR  - https://doi.org/10.11648/j.ijcems.20220801.11
AB  - Background: Type 2 Diabetes Mellitus affects patients’ quality of life. The my ePRO app was constructed to collect patient-reported outcomes in an investigator free study - DePRO study. We aimed to describe the qualitative and quantitative feedback received during user experience testing in a diabetes mellitus type 2 focus group. Methods: Metformin containing drug taking patients aged 18 years or older completed a 37-item qualitative questionnaire as the quantitative 6 scales and 26 items containing User Experience Questionnaire (UEQ) in a single focus group interview. The qualitative interview addressed feedback to 1) the download of the app, 2) scanning the 2D matrix code, 3) informed consent form, 4) demographic questionnaire and the 3 PRO instruments EQ-5D-5L, SDSCA and DTSQ. Results: Nine T2DM patients, 3 female and 6 male, aged 55-88 years were interviewed for 45 to 65 minutes. Patients expressed their need of lay language within the app, criticized the length of the informed consent form, the amount of health information, missed pictures of the drugs they scanned and judged the questions to income and education as too indiscreet. As positive feedback patient reported that everything was fine, the questions were self-explaining and could be read without glasses. The UEC scales (mean; variances) Perspicuity (0.722; 1.73), Efficiency (0.5; 0.89) and Novelty (0.25; 1.13) were rated neutral, Attractiveness (0.854: 0.63), Dependability (1.031; 0.1) and Stimulation (1.094; 0.39) represent a positive evaluation. Discussion: User experience testing provided insight into usage, challenges and areas of improvement of my ePRO app in a type 2 Diabetes Mellitus focus group. User experiences were implemented in the final app. The quantitative feedback was compared to a benchmark data set, to which the my ePRO app means were below average in all scales. Understanding patient view, leads to a better design of health apps and study conduct.
VL  - 8
IS  - 1
ER  -

Copy | Download